
Revenue Growth Benchmarks
Top-line performance metrics of companies across industries and countries
Top 10 Immunology Pharma and Biotech Companies
In the last fiscal year, only three companies Johnson & Johnson, Sanofi and Amgen reported growth in revenues while Pfizer was the laggard reporting 42% decline in annual revenues. However, these companies grew at an average of 5% over the last 5 years.
[ 1: LTM Sales in USD Biliion | Red Shading: Companies with negative growth in period | Green Shading: Top 2 companies by growth rank in period ]
Company | HQ | Reported | Latest | LTM | year-on-year % | CAGR | Growth Rank | ||||||||||||
Currency | FQ | Sales1 | 3m | 6m | 9m | ltm | 1y | 2y | 3y | 5y | 6m | LTM | 3ycagr | 5ycagr | |||||
Johnson & Johnson | USA | USD | 2023-12 | 93.02 | 7.3% | 7.0% | 6.8% | 6.5% | 6.5% | 4.0% | 1.0% | 0.9% | 2 | 2 | 8 | 8 | |||
Roche Holding AG | CHE | CHF | 2023-12 | 67.29 | na | -6.5% | na | -8.2% | -8.2% | -1.9% | 1.2% | 1.2% | 9 | 9 | 7 | 7 | |||
Pfizer Inc | USA | USD | 2023-12 | 58.50 | -41.3% | -41.4% | -46.1% | -41.7% | -41.7% | -15.2% | 12.0% | 7.5% | 10 | 10 | 2 | 4 | |||
AbbVie Inc | USA | USD | 2023-12 | 54.32 | -5.4% | -5.7% | -5.4% | -6.4% | -6.4% | -1.7% | 5.8% | 10.6% | 8 | 8 | 4 | 3 | |||
Novartis AG | CHE | CHF | 2023-12 | 51.02 | -0.3% | 1.7% | 0.6% | 1.1% | -0.3% | -0.2% | -3.1% | -2.5% | 3 | 5 | 9 | 9 | |||
Sanofi SA | FRA | EUR | 2023-12 | 50.27 | na | 1.2% | na | 2.3% | 2.3% | 8.9% | 7.5% | 5.4% | 4 | 3 | 3 | 5 | |||
AstraZeneca PLC | GBR | GBP | 2023-12 | 45.80 | 3.2% | -0.6% | 0.7% | 1.4% | -0.6% | 13.4% | 22.3% | 15.7% | 5 | 4 | 1 | 1 | |||
Bristol-Myers Squibb Co | USA | USD | 2023-12 | 45.01 | 0.6% | -0.8% | -2.4% | -2.5% | -2.5% | -1.5% | 1.9% | 14.8% | 6 | 6 | 6 | 2 | |||
Amgen Inc | USA | USD | 2023-12 | 28.19 | 19.8% | 11.9% | 10.0% | 7.1% | 7.1% | 4.2% | 3.5% | 3.5% | 1 | 1 | 5 | 6 | |||
Biogen Inc | USA | USD | 2023-12 | 9.84 | -6.2% | -2.7% | -3.5% | -3.3% | -3.3% | -5.4% | -9.9% | -6.1% | 7 | 7 | 10 | 10 | |||
Source: Annual Filings, Company Website | |||||||||||||||||||
Decide Fearlessly
ΒιΆΉΚΣΖ΅ is a global research analytics and advisory firm with over 20 years of experience in helping organizations take strategic business and investment decisions fearlessly and with utmost conviction.
Connect with us
Reach out to us
Β© , ΒιΆΉΚΣΖ΅. All rights reserved.